|
Feliciangeli E, Albaladejo-Gonzalez A, Garcia-Rodriguez J, Lazaro-Sanchez A, Borg R, Pimentel-Caceres P, Soriano-Polo D, Rodriguez-Braun E, Balsalobre-Yago J, Martinez-Ortiz MJ, Wikstrom-Fernandez S, Murillo-Herrera A, Garcia-Garcia T, Garcia-Solano J, Conesa-Zamora P, Luengo-Gil G. Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer. Sci Rep. 2025 Jul 1;15(1):21626. doi: 10.1038/s41598-025-04962-w. PubMed PMID: 40594059.
AÑO: 2025; IF: 3.9
|
40594059
|
Postigo-Corrales F, Beltran-Videla A, Lazaro-Sanchez AD, Hurtado AM, Conesa-Zamora P, Arroyo AB, Luengo-Gil G. Docetaxel Resistance in Breast Cancer: Current Insights and Future Directions. Int J Mol Sci. 2025 Jul 23;26(15):7119. doi: 10.3390/ijms26157119. PubMed PMID: 40806254.
AÑO: 2025; IF: 4.9
|
|
Lago-Ballester F, Martinez-Orea A, Laorden-Carrasco A, Diaz-Carrasco MS, Titos-Arcos JC, Mira-Sirvent MC, Luengo-Gil G, Martinez-Penella M. Effectiveness and Safety of Sacituzumab Govitecan in Real-World Clinical Practice in Patients with Metastatic Triple-Negative and HR+/HER2-Negative Breast Cancer. Biomedicines. 2025 Aug 23;13(9):2059. doi: 10.3390/biomedicines13092059. PubMed PMID: 41007623; PubMed Central PMCID: PMC12467514.
AÑO: 2025; IF: 3.9
|
|
Perez-Parra D, Postigo-Corrales F, Cruz Santos AF, Sanchez-Espinosa A, Acosta-Ortega J, Carrillo-Vicente R, Lopez-Abellan MD, Conesa-Zamora P, Luengo-Gil G, Hurtado-Lopez AM. Characterization and Prognostic Impact of Fascin Expression in the Tumor Microenvironment of Triple-Negative Breast Cancer: Clues for a Tailored Therapy. Lab Invest. 2025 Nov 28:104268. doi: 10.1016/j.labinv.2025.104268. Online ahead of print. PubMed PMID: 41319754.
AÑO: 2025; IF: 4.2
|
|
Sanchez-Villalobos JM, Serna-Berna A, Salinas-Ramos J, Escolar-Perez PP, Luengo-Gil G, Andreu-Galvez M, Martinez-Alonso E, Alcaraz M. Safety and Effectiveness of Volumetric Modulated Arc Therapy-Based Stereotactic Radiosurgery for Posterior Fossa Brain Metastases: A Single-Centre Experience. J Clin Med. 2025 Dec 2;14(23):8540. doi: 10.3390/jcm14238540. PubMed PMID: 41375843.
AÑO: 2025; IF: 2.9
|